Dr. Xiao-Kang Li is currently a Chief of the Laboratory of the Transplantation Immunology, National Research Institute for Child Health & Development in Japan. His main research focus is in the area of immunobiology of regulatory T cells, dendritic cells during immune response to autoantigens and transplantation antigens utilization an integrated basic, clinical and translational approach. His efforts also have focused on understanding the basic processes that control T cell activation and tolerance. He proposed several new approaches for Treg cell-based immunotherapy and gene therapy in transplant rejection. He has published more than 150 original articles in peer-reviewed SCI-cited international journals includingAm J Transplant,Transplantation, Mol Ther, Gene Ther,Hepatology,J Lab Clin Med, J Gene Med,Mol.Cell.Biol. Transpl Immunol, BBRC, J Pharmacol Exp Theretc. He is the editorial board member ofInternational ImmunopharmacologyJournalHypotheses andResearch. He received the International Young Investigator Award and Biotest-ESOT-Research Award in 1996.

Research Field of Interest

1. T cell, DC immunobiology;
2. Immune tolerance and regulation;
3. Transplantation;

4. Gene therapy;

5. Stem cell biology

报告题目：Molecular hydrogen and it’s applications in medical science